Clinical Trial Update: Treatment of Refractory Diabetic Macular Edema With Infliximab [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating infliximab for refractory diabetic macular edema was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: University of Athens | Conditions: Diabetic Macular Edema, Visual Acuity | Phase 3 | Status: TERMINATED